|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Aligos Therapeutics, Inc. (ALGS) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
14 |
|
|
|
Total
Direct Shares :
|
10,901,460 |
|
|
Total
Indirect Shares :
|
24,718,117 |
| |
%
Held by Insiders:
|
15.14% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Scopa James Paul |
|
2023-10-25 |
183,083 |
2023-10-25 |
0 |
| Blatt Lawrence |
|
2023-10-25 |
1,847,575 |
2023-10-25 |
273,058 |
| Woiwode Thomas |
Director |
2021-06-11 |
4,452 |
2021-06-11 |
862,444 |
| Nuechterlein Carole |
|
2020-10-20 |
0 |
2023-10-25 |
11,025,941 |
| Quan Lucinda Y. |
See Remarks |
2020-10-20 |
375,547 |
2020-10-20 |
9,258 |
| Beigelman Leonid |
President, Director |
2020-10-20 |
1,026,991 |
2020-10-20 |
228,659 |
| Vivo Capital Surplus Fund Viii, L.p. |
10% Owner |
2020-10-20 |
0 |
2020-10-20 |
430,372 |
| Wellington Biomedical Innovation Master Investors |
10% Owner |
2020-10-20 |
1,906,191 |
2020-10-20 |
0 |
| Versant Vantage I, L.p. |
10% Owner |
2020-10-20 |
2,429,895 |
2020-10-20 |
862,444 |
| Symons Julian A. |
See Remarks |
2020-10-20 |
394,064 |
|
0 |
| Novo A/s |
10% Owner |
2020-10-20 |
2,614,563 |
2020-10-20 |
0 |
| Glaub Kathleen Sereda |
Director |
2020-10-15 |
59,550 |
|
0 |
| Hirth Peter |
Director |
2020-10-15 |
59,549 |
|
0 |
| Roche Finance Ltd |
10% Owner |
|
0 |
2023-10-25 |
11,025,941 |
|
|
